Patent · US Active

Bispecific degraders

US12060366B2 · kind B2 · utility

0Cited by
0References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 27, 2019
Grant dateAug 13, 2024
Priority date
Expiry dateSep 6, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are degraders, pharmaceutical compositions containing them, and methods of making and using the degraders to treat diseases and disorders characterized by aberrant protein activity that can be targeted by cereblon.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.